Delve Health
Delve Health provides a unified clinical trial compliance and retention platform combining eCOA/ePRO, wearable digital endpoints, human concierge support, and real-time analytics. The company serves pharmaceutical, biotech, medtech, and research site clients across 40+ countries and seven therapeutic areas.
- Company typePrivate
- Founded2020
- HeadquartersMinneapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Delve Health does
Delve Health is a private clinical trial technology company founded in 2020 and headquartered in Minneapolis, Delaware-incorporated. The company operates a unified compliance and retention platform combining eCOA/ePRO, wearable-driven digital endpoints, human concierge patient support, multimedia eConsent, real-time analytics, and device logistics into a single operating model. The platform harmonizes signals from 25+ wearable devices through 70+ validated algorithms spanning ECG, glucose/CGM, activity, sleep, respiratory, and cardiovascular modalities, with alignment to FDA Digital Health Technology guidance, the Digital Medicine Society V3 framework, and ICH E6(R3). Concierge-as-a-Service™ provides protocol-trained human patient support in 120+ languages, delivering secondary screening, device troubleshooting, medication reminders, and site escalation workflows with documented outcomes including 92-98% diary completion, 2-3x retention uplift, and 87% deviation prevention. Compliance certifications span HIPAA, GDPR, FDA 21 CFR Part 11, GCP, ISO 9001, and ISO 27001.
Revenue derives from subscription-based enterprise platform licensing sold via direct sales to pharmaceutical sponsors, biotech, medtech, and research site customers across seven therapeutic areas (dermatology, oncology, rare disease, diabetes/obesity, CNS, cardiology, respiratory). Pricing is quote-based and not publicly disclosed; contracts are multi-year and scoped per study. Named customers include Pfizer, Regeneron, and Otsuka (pharma); Inari (biotech); RTI, Atlas, MCRA, and PDC-CRO (CROs); CVS and Rainier Research (sites). The company operates globally across 40+ countries with 3,500+ devices provisioned and supports CTMS integrations with CRIO and Clinical Conductor, plus open API delivery to EDC systems via REST/webhook with CDISC packages. Total disclosed funding is approximately $609K across four rounds from 2015-2024, including a DayOne accelerator participation in August 2024 and prior gBETA Medtech involvement. Leadership includes co-founder and CEO Wessam Sonbol and CTO T Swidan.
Delve Health firmographics
Firmographics- Name
- Delve Health
- Legal name
- Delve Health, Inc.
- Website
- https://delvehealth.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Delve Health provides a unified clinical trial compliance and retention platform combining eCOA/ePRO, wearable digital endpoints, human concierge support, and real-time analytics. The company serves pharmaceutical, biotech, medtech, and research site clients across 40+ countries and seven therapeutic areas.
- Ownership category
- akta.pro rank
Delve Health industry classification
Industry- Product category
- Clinical Trial Technology Platform
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372)
- akta.pro primary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
- akta.pro secondary industries
- eConsent & Digital Identity for Trials (HLACAOAE), Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL)
Keywords
Where Delve Health is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Markets served
Delve Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Trial Technology Platform: Delve Health generates revenue through licensing its unified compliance and retention platform to pharmaceutical, biotech, and medtech sponsors running clinical trials. Revenue derives from platform access, configuration, and per-study deployment. The model involves enterprise contracts with outcomes-scoped integrated engagement rather than pure per-user pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise platform licensing with per-study engagement |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Delve Health product offering
Product offeringCore offering
Delve Health provides a unified clinical trial compliance and retention platform combining eCOA/ePRO, wearable and digital endpoint data capture, human multilingual concierge support, eConsent, real-time analytics, and device provisioning. The platform serves pharmaceutical, biotech, medtech, and research site sponsors running decentralized and hybrid clinical trials, with documented 92-98% diary completion and 2-3x retention uplift.
Product overview
Delve Health is a clinical trial compliance and retention platform combining eCOA/ePRO, wearables and digital endpoints, human concierge support, eConsent, real-time analytics, and device logistics into a unified operating model. The platform serves pharmaceutical, biotech, medtech, and research site clients across therapeutic areas including dermatology, oncology, rare disease, diabetes/obesity, CNS, cardiology, and respiratory. Key products include the eCOA & ePRO Platform, Wearables & Digital Endpoints (70+ validated algorithms), Concierge-as-a-Service™ (120+ languages), eConsent, Real-Time Analytics Dashboard, Device Provisioning & Logistics, Digital Biomarkers, Site Enablement, Post-Market Studies, Device Integration, and Signal Quality Control — all unified to protect completion, retention, and endpoint integrity in decentralized and hybrid clinical trials.
Differentiator
Problem solved
Functional benefit
Brands
- Perta: Product of Delve Health
- StudyPal
Products and services
- eCOA & ePRO Platform
Quantifiable outcome
- 92-98% diary/ePRO completion range supported by operational follow-up
- +8 more outcomes
Companies that use Delve Health
Customer profileNamed customers13 records
Segments4 records
Ideal customer profiles5 records
Delve Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability7 records
Feature6 records
Delve Health partnerships and signals
Strategic signalScale indicators12 records
Recent moves6 records
Expansion highlights5 records
Delve Health competitors and assessment
Company assessmentDirect peers
- Medable: Direct eCOA/decentralized clinical trial platform competitor with a comparable offering across eCOA, eConsent, telehealth, and wearables. Both target the same pharma/biotech/CRO buyer for hybrid and DCT trial execution.
- Clario: Direct peer in eCOA, ePRO, and digital endpoints with deep wearable/sensor validation heritage (formerly ERT/Bioclinica). Competes head-to-head in regulated endpoint capture for pharma trials.
- Signant Health: Direct eCOA, eConsent, patient engagement, and digital endpoint competitor serving global pharma and biotech. Overlaps Delve in randomization supply, ePRO, and decentralized trial support.
- Castor: Direct peer in eClinical/eCOA and decentralized trial enablement for pharma and academic sponsors. Comparable mid-market positioning with API-driven eCRF, ePRO, and eConsent.
- YPrime: Direct peer in eCOA, IRT, and clinical supply technology with strong pharma/biotech overlap. Competes on patient-facing data capture and configurable electronic clinical outcome assessments.
- THREAD Research: Direct decentralized clinical trial platform peer offering eCOA, eConsent, telehealth, and wearables integrations to biopharma. Targets the same DCT operating model as Delve.
- ObvioHealth: Direct virtual/DCT competitor with eCOA, eConsent, and remote monitoring for pharma trials. Comparable patient-facing data capture and decentralized operations focus.
Broad incumbents
- Veeva Systems: Broad incumbent in life sciences cloud (Vault CDB, Vault EDC, Vault CTMS) with growing eCOA and clinical operations footprint. Competes indirectly through bundled enterprise clinical suites.
- Medidata Solutions (Dassault Systèmes): Broad incumbent with Rave EDC, Rave eCOA, and decentralized trial offerings tightly integrated into enterprise pharma workflows. Largest scaled competitor across full clinical operations stack.
Emerging players
- Koneksa: Emerging digital endpoint/wearables-focused peer with validated algorithms for respiratory, CNS, and oncology trials. Comparable in digital biomarker and sensor-based endpoint validation but narrower eCOA footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Delve Health social profiles
Digital presenceDelve Health compliance and trust
Trust signalCompliance8 records
Delve Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Delve Health leadership team
Management profileNumber of profiles
Profiles2 records
Delve Health funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Delve Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Delve Health
What does Delve Health do?
Delve Health provides a unified clinical trial compliance and retention platform combining eCOA/ePRO, wearable and digital endpoint data capture, human multilingual concierge support, eConsent, real-time analytics, and device provisioning. The platform serves pharmaceutical, biotech, medtech, and research site sponsors running decentralized and hybrid clinical trials, with documented 92-98% diary completion and 2-3x retention uplift.
Is Delve Health a public or private company?
Delve Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Delve Health founded?
Delve Health was founded in 2020. It employs 11 to 50 people.
Where is Delve Health based?
Delve Health is headquartered in Minneapolis, United States, in the North America region.
How does Delve Health make money?
One revenue line is on record: clinical Trial Technology Platform.
Who are Delve Health's main competitors?
Direct peers on record are Medable, Clario, Signant Health, Castor, YPrime, THREAD Research and ObvioHealth. Broad incumbents are Veeva Systems and Medidata Solutions (Dassault Systèmes). Koneksa is listed as an emerging player.
Does Delve Health have an API?
Yes. Delve Health offers open endpoint APIs for exporting harmonized endpoints directly to EDC systems, analytics pipelines, and regulatory submission packages. The API supports REST pull and webhook push, batch delivery, CDISC packages, and Parquet format with versioned contracts, provenance, and audit trail. Direct EDC delivery is supported. Note: No public developer portal or SDK documentation URL was found in the source material.
What industry is Delve Health in?
Delve Health's product category is Clinical Trial Technology Platform. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAOAE, eConsent & Digital Identity for Trials. Its NAICS code is 518 and its SIC code is 7370.